Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2011-04-01 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LOUVECIENNES (78430), Yvelines
PHARMACIE S.V.M.F : revenue, balance sheet and financial ratios
PHARMACIE S.V.M.F is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LOUVECIENNES (78430),
this company of category PME
shows in 2023 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE S.V.M.F (SIREN 531444875)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 880 177 €
N/C
N/C
N/C
N/C
1 196 500 €
1 338 629 €
1 368 109 €
Net income
79 519 €
65 671 €
89 805 €
161 647 €
111 134 €
96 591 €
42 660 €
49 664 €
57 336 €
72 920 €
EBITDA
N/C
N/C
122 837 €
N/C
N/C
N/C
N/C
62 108 €
83 750 €
119 540 €
Net margin
N/C
N/C
4.8%
N/C
N/C
N/C
N/C
4.2%
4.3%
5.3%
Revenue and income statement
In 2025, PHARMACIE S.V.M.F generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 73 k€ -> 80 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
79 519 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.787%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.202%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
219.64
184.624
157.639
134.957
107.636
86.768
65.022
46.537
36.728
27.787
Financial autonomy
28.733
32.301
36.1
38.617
43.024
48.026
54.28
60.205
64.785
69.202
Repayment capacity
10.969
17.108
19.332
None
None
None
None
5.071
None
None
Cash flow / Revenue
6.176%
3.864%
3.605%
None%
None%
None%
None%
5.031%
None%
None%
Sector positioning
Debt ratio
27.792025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE S.V.M.F (27.79) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
69.2%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE S.V.M.F (69.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.07 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE S.V.M.F (5.07) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 214.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
214.606
Liquidity indicators evolution PHARMACIE S.V.M.F
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
182.331
191.437
206.709
165.854
182.604
221.003
261.68
224.034
222.232
214.606
Interest coverage
19.804
21.368
15.426
None
None
None
None
4.6
None
None
Sector positioning
Liquidity ratio
214.612025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of PHARMACIE S.V.M.F (214.61) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
4.6x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE S.V.M.F (4.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE S.V.M.F
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
168 059 €
183 218 €
181 078 €
0 €
0 €
0 €
0 €
333 844 €
0 €
0 €
Inventory turnover (days)
31
33
36
0
0
0
0
40
0
0
Customer payment term (days)
11
12
12
286
228
0
0
9
0
0
Supplier payment term (days)
28
30
30
808
737
0
0
38
0
0
Positioning of PHARMACIE S.V.M.F in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE S.V.M.F is estimated at
1 263 168 €
(range 857 192€ - 1 982 085€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
857k€1263k€1982k€
1 263 168 €Range: 857 192€ - 1 982 085€
NAF 5 année 2025
Valuation method used
Net Income Multiple
79 519 €
×
15.9x
=1 263 169 €
Range: 857 192€ - 1 982 086€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE S.V.M.F with other companies in the same sector:
Frequently asked questions about PHARMACIE S.V.M.F
What is the revenue of PHARMACIE S.V.M.F ?
The revenue of PHARMACIE S.V.M.F in 2023 is 1.9 M€.
Is PHARMACIE S.V.M.F profitable?
Yes, PHARMACIE S.V.M.F generated a net profit of 80 k€ in 2025.
Where is the headquarters of PHARMACIE S.V.M.F ?
The headquarters of PHARMACIE S.V.M.F is located in LOUVECIENNES (78430), in the department Yvelines.
Where to find the tax return of PHARMACIE S.V.M.F ?
The tax return of PHARMACIE S.V.M.F is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE S.V.M.F operate?
PHARMACIE S.V.M.F operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart